Nevro Corp (NASDAQ:NVRO) shares reached a new 52-week high on Monday . The stock traded as high as $100.33 and last traded at $99.86, with a volume of 444,602 shares traded. The stock had previously closed at $97.96.

Several research analysts recently weighed in on the stock. JMP Securities upped their price objective on shares of Nevro Corp from $90.00 to $110.00 and gave the stock a “market outperform” rating in a research report on Tuesday, August 9th. Bank of America Corp. started coverage on shares of Nevro Corp in a research report on Monday, August 8th. They set a “buy” rating and a $100.00 price target on the stock. William Blair started coverage on shares of Nevro Corp in a research report on Tuesday, July 19th. They set an “outperform” rating on the stock. Piper Jaffray Cos. started coverage on shares of Nevro Corp in a research report on Friday, July 22nd. They set an “overweight” rating and a $98.00 price target on the stock. Finally, Zacks Investment Research upgraded shares of Nevro Corp from a “hold” rating to a “buy” rating and set a $109.00 price target on the stock in a research report on Friday, August 12th. Ten investment analysts have rated the stock with a buy rating, The stock currently has an average rating of “Buy” and a consensus target price of $102.43.

The firm’s 50 day moving average price is $84.24 and its 200-day moving average price is $68.44. The company’s market capitalization is $2.85 billion.

Nevro Corp (NASDAQ:NVRO) last posted its quarterly earnings data on Monday, August 8th. The company reported ($0.31) earnings per share for the quarter, beating the Zacks’ consensus estimate of ($0.47) by $0.16. The company had revenue of $55.40 million for the quarter, compared to analysts’ expectations of $45.11 million. The firm’s quarterly revenue was up 385.5% on a year-over-year basis. On average, equities research analysts forecast that Nevro Corp will post ($1.43) EPS for the current year.

In other news, VP Andre Walker sold 4,000 shares of Nevro Corp stock in a transaction dated Thursday, June 2nd. The stock was sold at an average price of $73.50, for a total transaction of $294,000.00. Following the transaction, the vice president now directly owns 4,197 shares of the company’s stock, valued at approximately $308,479.50. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Wilfred E. Jaeger sold 155,160 shares of Nevro Corp stock in a transaction dated Wednesday, August 17th. The shares were sold at an average price of $97.31, for a total value of $15,098,619.60. The disclosure for this sale can be found here.

Nevro Corp. is a medical device company. The Company has developed and commercialized a neuromodulation platform for the treatment of chronic pain. The Company’s Senza system is a spinal cord stimulation (SCS) system that delivers its HF10 therapy. HF10 therapy is designed to deliver neuromodulation solutions for treating chronic pain.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.